Bosentan Tablet, For Suspension
Product Images NDC 70771-1908

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Bosentan (NDC 70771-1908). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (008fc213 Caa0 4d52 9ee2 E3628c19b90b 01)

Each tablet contains 32 mg of anhydrous bosentan. The usual dosage is to disperse tablets for oral suspension, or tablet half, in a minimal amount of water immediately before administration. Store the tablets at 20°C to 25°C (68°F to 77°F) and use them within 7 days. This package is child-resistant, keep all drugs out of the reach of children. It is important to read the accompanying prescribing information carefully and dispense the medication guide to each patient. The tablets for oral suspension contain Phenylalanine at 2.08 mg per tablet.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.